Do you ever consider treating the axilla in patients with multiple nodes with ITCs?  

Does the axilla have to be addressed surgically or with RT, given that the AMAROS trial eligibility criteria were amended to address sentinel lymph nodes with only ITC to be node negative, along with the results of IBCSG 23-01?  Does it change if the patient is triple negative?  



Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Community Practice